AIM ImmunoTech Inc.

AMEX: AIM · Real-Time Price · USD
2.52
-0.05 (-1.95%)
At close: Aug 15, 2025, 3:58 PM
2.58
2.38%
After-hours: Aug 15, 2025, 05:57 PM EDT

AIM ImmunoTech Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
1.7M 5.44M 27.05M 32.09M
Short-Term Investments
2.28M 7.63M 7.14M 16.18M
Long-Term Investments
n/a n/a n/a -25.02M
Other Long-Term Assets
1.11M 1.69M 1.2M 1.32M
Receivables
n/a 1.18M 1.68M 1.64M
Inventory
n/a -302K n/a n/a
Other Current Assets
199K 302K 455K n/a
Total Current Assets
4.18M 14.56M 36.32M 50.21M
Property-Plant & Equipment
726K 824K 1.02M 4.2M
Goodwill & Intangibles
2.59M 2.31M 1.94M 1.97M
Total Long-Term Assets
4.43M 4.83M 4.17M 7.49M
Total Assets
8.61M 19.38M 40.49M 57.7M
Account Payables
6.38M 6.44M 377K 198K
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
2.31M n/a n/a n/a
Other Current Liabilities
1K 1.57M 1K n/a
Total Current Liabilities
9.54M 8.65M 1.36M 673K
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a 35K
Total Long-Term Liabilities
395K 495K 659K 147K
Total Liabilities
9.93M 9.15M 2.02M 820K
Total Debt
2.94M 718K 837K 149K
Common Stock
66K 49K 48K 48K
Retained Earnings
-426.83M -409.51M -380.55M -361.1M
Comprehensive Income
n/a -0.00 n/a n/a
Shareholders Equity
-1.32M 10.23M 38.47M 56.88M
Total Investments
2.28M 7.63M 7.14M 16.18M